TAK-981

· Takeda Pharmaceutical Company Limited

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TAK-981, covering 2024-06-14 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]

See pricing